Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles
The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances tumorigenicity and also accounts for radiation and chemotherapy resistance. Targeting the EGFRvIII deletion mutant may lead to improved GBM the...
Saved in:
Published in | Journal of neuro-oncology Vol. 124; no. 1; pp. 13 - 22 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.08.2015
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances tumorigenicity and also accounts for radiation and chemotherapy resistance. Targeting the EGFRvIII deletion mutant may lead to improved GBM therapy and better patient prognosis. Multifunctional magnetic nanoparticles serve as a potential clinical tool that can provide cancer cell targeted drug delivery, imaging, and therapy. Our previous studies have shown that an EGFRvIII-specific antibody and cetuximab (an EGFR- and EGFRvIII-specific antibody), when bioconjugated to IONPs (EGFRvIII-IONPs or cetuximab-IONPs respectively), can simultaneously provide sensitive cancer cell detection by magnetic resonance imaging (MRI) and targeted therapy of experimental GBM. In this study, we investigated whether cetuximab-IONPs can additionally allow for the radiosensitivity enhancement of GBM. Cetuximab-IONPs were used in combination with single (10 Gy × 1) or multiple fractions (10 Gy × 2) of ionizing radiation (IR) for radiosensitization of EGFRvIII-overexpressing human GBM cells in vitro and in vivo after convection-enhanced delivery (CED). A significant GBM antitumor effect was observed in vitro after treatment with cetuximab-IONPs and subsequent single or fractionated IR. A significant increase in overall survival of nude mice implanted with human GBM xenografts was found after treatment by cetuximab-IONP CED and subsequent fractionated IR. Increased DNA double strands breaks (DSBs), as well as increased reactive oxygen species (ROS) formation, were felt to represent the mediators of the observed radiosensitization effect with the combination therapy of IR and cetuximab-IONPs treatment. |
---|---|
AbstractList | The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances tumorigenicity and also accounts for radiation and chemotherapy resistance. Targeting the EGFRvIII deletion mutant may lead to improved GBM therapy and better patient prognosis. Multifunctional magnetic nanoparticles serve as a potential clinical tool that can provide cancer cell targeted drug delivery, imaging, and therapy. Our previous studies have shown that an EGFRvIII-specific antibody and cetuximab (an EGFR- and EGFRvIII-specific antibody), when bioconjugated to IONPs (EGFRvIII-IONPs or cetuximab-IONPs respectively), can simultaneously provide sensitive cancer cell detection by magnetic resonance imaging (MRI) and targeted therapy of experimental GBM. In this study, we investigated whether cetuximab-IONPs can additionally allow for the radiosensitivity enhancement of GBM. Cetuximab-IONPs were used in combination with single (10 Gy × 1) or multiple fractions (10 Gy × 2) of ionizing radiation (IR) for radiosensitization of EGFRvIII-overexpressing human GBM cells in vitro and in vivo after convection-enhanced delivery (CED). A significant GBM antitumor effect was observed in vitro after treatment with cetuximab-IONPs and subsequent single or fractionated IR. A significant increase in overall survival of nude mice implanted with human GBM xenografts was found after treatment by cetuximab-IONP CED and subsequent fractionated IR. Increased DNA double strands breaks (DSBs), as well as increased reactive oxygen species (ROS) formation, were felt to represent the mediators of the observed radiosensitization effect with the combination therapy of IR and cetuximab-IONPs treatment. The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances tumorigenicity and also accounts for radiation and chemotherapy resistance. Targeting the EGFRvIII deletion mutant may lead to improved GBM therapy and better patient prognosis. Multifunctional magnetic nanoparticles serve as a potential clinical tool that can provide cancer cell targeted drug delivery, imaging, and therapy. Our previous studies have shown that an EGFRvIII-specific antibody and cetuximab (an EGFR- and EGFRvIII-specific antibody), when bioconjugated to IONPs (EGFRvIII-IONPs or cetuximab-IONPs respectively), can simultaneously provide sensitive cancer cell detection by magnetic resonance imaging (MRI) and targeted therapy of experimental GBM. In this study, we investigated whether cetuximab-IONPs can additionally allow for the radiosensitivity enhancement of GBM. Cetuximab-IONPs were used in combination with single (10 Gy × 1) or multiple fractions (10 Gy × 2) of ionizing radiation (IR) for radiosensitization of EGFRvIII-overexpressing human GBM cells in vitro and in vivo after convection-enhanced delivery (CED). A significant GBM antitumor effect was observed in vitro after treatment with cetuximab-IONPs and subsequent single or fractionated IR. A significant increase in overall survival of nude mice implanted with human GBM xenografts was found after treatment by cetuximab-IONP CED and subsequent fractionated IR. Increased DNA double strands breaks (DSBs), as well as increased reactive oxygen species (ROS) formation, were felt to represent the mediators of the observed radiosensitization effect with the combination therapy of IR and cetuximab-IONPs treatment. The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances tumorigenicity and also accounts for radiation and chemotherapy resistance. Targeting the EGFRvIII deletion mutant may lead to improved GBM therapy and better patient prognosis. Multifunctional magnetic nanoparticles serve as a potential clinical tool that can provide cancer cell targeted drug delivery, imaging, and therapy. Our previous studies have shown that an EGFRvIII-specific antibody and cetuximab (an EGFR- and EGFRvIII-specific antibody), when bioconjugated to IONPs (EGFRvIII-IONPs or cetuximab-IONPs respectively), can simultaneously provide sensitive cancer cell detection by magnetic resonance imaging (MRI) and targeted therapy of experimental GBM. In this study, we investigated whether cetuximab-IONPs can additionally allow for the radiosensitivity enhancement of GBM. Cetuximab-IONPs were used in combination with single (10Gy x 1) or multiple fractions (10Gy x 2) of ionizing radiation (IR) for radiosensitization of EGFRvIII-overexpressing human GBM cells in vitro and in vivo after convection-enhanced delivery (CED). A significant GBM antitumor effect was observed in vitro after treatment with cetuximab-IONPs and subsequent single or fractionated IR. A significant increase in overall survival of nude mice implanted with human GBM xenografts was found after treatment by cetuximab-IONP CED and subsequent fractionated IR. Increased DNA double strands breaks (DSBs), as well as increased reactive oxygen species (ROS) formation, were felt to represent the mediators of the observed radiosensitization effect with the combination therapy of IR and cetuximab-IONPs treatment. The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances tumorigenicity and also accounts for radiation and chemotherapy resistance. Targeting the EGFRvIII deletion mutant may lead to improved GBM therapy and better patient prognosis. Multifunctional magnetic nanoparticles serve as a potential clinical tool that can provide cancer cell targeted drug delivery, imaging, and therapy. Our previous studies have shown that an EGFRvIII-specific antibody and cetuximab (an EGFR- and EGFRvIII-specific antibody), when bioconjugated to IONPs (EGFRvIII-IONPs or cetuximab-IONPs respectively), can simultaneously provide sensitive cancer cell detection by magnetic resonance imaging (MRI) and targeted therapy of experimental GBM. In this study, we investigated whether cetuximab-IONPs can additionally allow for the radiosensitivity enhancement of GBM. Cetuximab-IONPs were used in combination with single (10 Gy 1) or multiple fractions (10 Gy 2) of ionizing radiation (IR) for radiosensitization of EGFRvIII-overexpressing human GBM cells in vitro and in vivo after convection-enhanced delivery (CED). A significant GBM antitumor effect was observed in vitro after treatment with cetuximab-IONPs and subsequent single or fractionated IR. A significant increase in overall survival of nude mice implanted with human GBM xenografts was found after treatment by cetuximab-IONP CED and subsequent fractionated IR. Increased DNA double strands breaks (DSBs), as well as increased reactive oxygen species (ROS) formation, were felt to represent the mediators of the observed radiosensitization effect with the combination therapy of IR and cetuximab-IONPs treatment. |
Author | Kaluzova, Milota Bouras, Alexandros Hadjipanayis, Costas G. |
AuthorAffiliation | 2 Winship Brain Tumor Center of Emory University, Winship Cancer Institute of Emory University, Atlanta, GA 30322 1 Brain Tumor Nanotechnology Laboratory, Department of Neurosurgery, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA |
AuthorAffiliation_xml | – name: 1 Brain Tumor Nanotechnology Laboratory, Department of Neurosurgery, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA – name: 2 Winship Brain Tumor Center of Emory University, Winship Cancer Institute of Emory University, Atlanta, GA 30322 |
Author_xml | – sequence: 1 givenname: Alexandros surname: Bouras fullname: Bouras, Alexandros organization: Brain Tumor Nanotechnology Laboratory, Department of Neurosurgery, Emory University School of Medicine, Winship Cancer Institute of Emory University – sequence: 2 givenname: Milota surname: Kaluzova fullname: Kaluzova, Milota organization: Brain Tumor Nanotechnology Laboratory, Department of Neurosurgery, Emory University School of Medicine, Winship Cancer Institute of Emory University – sequence: 3 givenname: Costas G. surname: Hadjipanayis fullname: Hadjipanayis, Costas G. email: chadjip@emory.edu organization: Brain Tumor Nanotechnology Laboratory, Department of Neurosurgery, Emory University School of Medicine, Winship Cancer Institute of Emory University, Winship Brain Tumor Center of Emory University, Winship Cancer Institute of Emory University, Department of Neurosurgery, Emory University School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25981803$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt2K1TAUhYOMOGeOPoA3UvDGmzhJ0yTtjSCDfzAwIArehTTd7cmhTWqSjp538KFN54zDjCBe5Wd_a-3ssM7QifMOEHpOyWtKiDyPlBJBMKEc05pITB6hDeWSYckkO0EbQoXEvKm-naKzGPeEkEoy-gSdlryps4Jt0K_PurM-gos22WubDgW4nXYGJnCp8H0R1nqAaGPS-WYYrW9HHZOfdNFmerYdhEmPxRD8j7Qrem2SD0UAA_O6ySLb-u6AjXf7ZdAJusIG77D_mZWF087POiRrRohP0eNejxGe3a5b9PX9uy8XH_Hl1YdPF28vsRGkTJi2nPdgeFXLmrWyZFVVUt3ITve8NmUruroqG9FowzpKWp6PLUDVcyZBEGBsi94cfeelnaAzedSgRzUHO-lwUF5b9bDi7E4N_lpVVVM3YjV4dWsQ_PcFYlKTjQbGUTvwS1RUkobWJRP1_1HRcMml4CSjL_9C934JLv_EDUUZ43nYLaJHygQfY4D-7t2UqDUW6hgLlWOh1lio1fnF_YHvFH9ykIHyCMRccgOEe63_6fobqvrJOg |
CitedBy_id | crossref_primary_10_3390_ijms25052529 crossref_primary_10_3390_ph17030300 crossref_primary_10_3390_polym15193969 crossref_primary_10_3892_or_2017_5937 crossref_primary_10_1007_s10967_018_5704_9 crossref_primary_10_3390_pharmaceutics15030722 crossref_primary_10_1016_j_semcancer_2022_06_007 crossref_primary_10_1007_s00381_020_05008_4 crossref_primary_10_1038_s41598_020_74746_x crossref_primary_10_1039_D1BM01401C crossref_primary_10_1080_09553002_2018_1478160 crossref_primary_10_2217_imt_16_11 crossref_primary_10_3390_mi15050559 crossref_primary_10_1007_s12274_020_2722_z crossref_primary_10_3389_fonc_2018_00624 crossref_primary_10_3390_pharmaceutics13111757 crossref_primary_10_1134_S0006297920090011 crossref_primary_10_1016_j_jmr_2018_03_004 crossref_primary_10_3390_nano10030504 crossref_primary_10_1111_bpa_12423 crossref_primary_10_3390_ijms21020579 crossref_primary_10_1002_wnan_1439 crossref_primary_10_3390_ijms20215243 crossref_primary_10_1007_s11060_018_2764_1 crossref_primary_10_3390_cancers13133185 crossref_primary_10_1007_s12094_020_02331_9 crossref_primary_10_1016_j_jddst_2023_104586 crossref_primary_10_1021_acsmedchemlett_9b00538 crossref_primary_10_1021_acs_bioconjchem_6b00168 crossref_primary_10_1007_s12272_020_01205_6 crossref_primary_10_1186_s12951_020_00684_5 crossref_primary_10_1080_02656736_2018_1430867 crossref_primary_10_1002_btm2_10256 crossref_primary_10_1016_j_lfs_2022_120729 crossref_primary_10_1038_s41467_020_19225_7 crossref_primary_10_1016_j_bbcan_2023_188996 crossref_primary_10_1007_s00018_019_03305_z crossref_primary_10_3390_pharmaceutics15102406 crossref_primary_10_3389_fphar_2018_00831 crossref_primary_10_1016_j_xphs_2024_03_017 crossref_primary_10_1016_j_jinorgbio_2020_111117 crossref_primary_10_2217_nnm_2020_0452 crossref_primary_10_1098_rsos_181790 crossref_primary_10_1002_adfm_202008171 crossref_primary_10_1007_s00795_017_0171_x crossref_primary_10_1016_j_nec_2020_12_004 crossref_primary_10_3389_fmedt_2021_791596 crossref_primary_10_3389_fchem_2021_651053 crossref_primary_10_3389_fbioe_2021_629832 crossref_primary_10_1186_s13041_024_01113_6 crossref_primary_10_1016_j_nec_2022_11_004 crossref_primary_10_1007_s00411_023_01037_0 |
Cites_doi | 10.1007/s11060-005-9059-z 10.1227/NEU.0b013e31826989ef 10.1073/pnas.91.6.2076 10.1016/j.radonc.2004.07.004 10.1016/j.freeradbiomed.2012.04.033 10.1016/j.jocn.2008.12.005 10.1016/j.ccr.2013.09.004 10.1007/s11051-012-1225-6 10.1073/pnas.91.16.7727 10.1215/15228517-2008-012 10.1088/0957-4484/20/11/115103 10.1038/nature08467 10.1634/theoncologist.2012-0458 10.1002/smll.200800261 10.1038/sj.onc.1207602 10.1038/sj.onc.1206788 10.4161/cbt.19591 10.1038/sj.onc.1206663 10.4103/0019-509X.49146 10.1016/j.bbrc.2012.07.108 10.1517/14712598.2011.582464 10.1007/s11060-010-0389-0 10.1126/science.1164382 10.3174/ajnr.A1590 10.1016/j.ccr.2005.03.003 10.1158/1078-0432.CCR-08-0147 10.1002/smll.200700784 10.1148/radiology.197.2.7480707 10.1016/j.nano.2011.02.008 10.1158/1078-0432.CCR-06-0946 10.4161/cbt.5.8.3118 10.1056/NEJMoa043330 10.1038/mt.2008.185 10.1158/0008-5472.CAN-10-1022 10.1021/cr2002596 10.1148/radiology.214.2.r00fe19568 10.1038/clpt.2008.296 10.1038/sj.bjc.6604943 10.1158/0008-5472.CAN-08-4853 10.1227/01.NEU.0000145865.25689.55 10.18632/oncotarget.3554 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media New York 2015 |
Copyright_xml | – notice: Springer Science+Business Media New York 2015 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1007/s11060-015-1807-0 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts PHMC-Proquest健康医学期刊库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central AUTh Library subscriptions: ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection Neurosciences Abstracts ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Public Health MEDLINE - Academic Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-7373 |
EndPage | 22 |
ExternalDocumentID | 3739184121 10_1007_s11060_015_1807_0 25981803 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural Feature |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: NS053454 – fundername: NINDS NIH HHS grantid: K08 NS053454 – fundername: NCI NIH HHS grantid: R01 CA176659 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHVE ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFJLC AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Y I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z81 Z82 Z83 Z87 Z8O Z8U Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 7TK 7XB 8FK K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c602t-1b55fec548783b7234421a97daf58c2b6d842969ac3d10b5d84bee4f537e60e33 |
IEDL.DBID | BENPR |
ISSN | 0167-594X |
IngestDate | Tue Sep 17 21:07:35 EDT 2024 Sat Oct 05 04:59:37 EDT 2024 Sat Aug 17 02:00:52 EDT 2024 Thu Oct 10 18:55:16 EDT 2024 Thu Sep 12 17:12:28 EDT 2024 Tue Oct 15 23:53:48 EDT 2024 Sat Dec 16 12:04:45 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Ionizing radiation Iron oxide nanoparticles Convection-enhanced delivery Magnetic resonance imaging Epidermal growth factor receptor Glioblastoma |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c602t-1b55fec548783b7234421a97daf58c2b6d842969ac3d10b5d84bee4f537e60e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Authors address: Dr. Alexandros Bouras, Dr. Milota Kaluzova and Dr. Costas G. Hadjipanayis Emory University, School of Medicine, Atlanta, GA 30322 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498963 |
PMID | 25981803 |
PQID | 1695133572 |
PQPubID | 37423 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4498963 proquest_miscellaneous_1709182368 proquest_miscellaneous_1695757650 proquest_journals_1695133572 crossref_primary_10_1007_s11060_015_1807_0 pubmed_primary_25981803 springer_journals_10_1007_s11060_015_1807_0 |
PublicationCentury | 2000 |
PublicationDate | 2015-08-01 |
PublicationDateYYYYMMDD | 2015-08-01 |
PublicationDate_xml | – month: 08 year: 2015 text: 2015-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Journal of neuro-oncology |
PublicationTitleAbbrev | J Neurooncol |
PublicationTitleAlternate | J Neurooncol |
PublicationYear | 2015 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Martens, Laabs, Gunther, Kemming, Zhu, Witte, Hagel, Westphal, Lamszus (CR11) 2008; 14 Bobo, Laske, Akbasak, Morrison, Dedrick, Oldfield (CR45) 1994; 91 Kuo, Yang (CR24) 2008; 22 Lammering, Valerie, Lin, Hewit, Schmidt-Ullrich (CR27) 2004; 72 Mukherjee, McEllin, Camacho, Tomimatsu, Sirasanagandala, Nannepaga, Hatanpaa, Mickey, Madden, Maher, Boothman, Furnari, Cavenee, Bachoo, Burma (CR6) 2009; 69 Gan, Kaye, Luwor (CR5) 2009; 16 Mahmoudi, Hofmann, Rothen-Rutishauser, Petri-Fink (CR19) 2012; 112 Eller, Longo, Hicklin, Canute (CR13) 2002; 51 Orringer, Koo, Chen, Kopelman, Sagher, Philbert (CR31) 2009; 85 Mendelsohn (CR7) 2002; 20 Eller, Longo, Kyle, Bassano, Hicklin, Canute (CR37) 2005; 56 CR14 Fan, Cheng, Gustafson, Charron, Zipper, Wong, Chen, Lau, Knobbe-Thomsen, Weller, Jura, Reifenberger, Shokat, Weiss (CR30) 2013; 24 Garrett, Eng (CR8) 2011; 11 Provenzale, Silva (CR32) 2009; 30 Mikkelsen, Wardman (CR38) 2003; 22 Sampson, Akabani, Archer, Berger, Coleman, Friedman, Friedman, Greer, Herndon, Kunwar, McLendon, Paolino, Petry, Provenzale, Reardon, Wong, Zalutsky, Pastan, Bigner (CR44) 2008; 10 Cohen, Chen, Shord, Fuchs, He, Zhao, Sickafuse, Keegan, Pazdur (CR9) 2013; 18 Klein, Sommer, Distel, Neuhuber, Kryschi (CR41) 2012; 425 Hadjipanayis, Fellows-Mayle, Deluca (CR43) 2008; 16 Parsons, Jones, Zhang, Lin, Leary, Angenendt, Mankoo, Carter, Siu, Gallia, Olivi, McLendon, Rasheed, Keir, Nikolskaya, Nikolsky, Busam, Tekleab, Diaz, Hartigan, Smith, Strausberg, Marie, Shinjo, Yan, Riggins, Bigner, Karchin, Papadopoulos, Parmigiani, Vogelstein, Velculescu, Kinzler (CR4) 2008; 321 Sun, Veiseh, Gunn, Fang, Hansen, Lee, Sze, Ellenbogen, Olson, Zhang (CR34) 2008; 4 Belda-Iniesta, Carpeno Jde, Saenz, Gutierrez, Perona, Baron (CR12) 2006; 5 Platt, Nduom, Kent, Freeman, Machaidze, Kaluzova, Wang, Mao, Hadjipanayis (CR15) 2012; 59 Hadjipanayis, Machaidze, Kaluzova, Wang, Schuette, Chen, Wu, Mao (CR20) 2010; 70 Caruso, Caffo, Alafaci, Raudino, Cafarella, Lucerna, Salpietro, Tomasello (CR33) 2011; 7 Nishikawa, Ji, Harmon, Lazar, Gill, Cavenee, Huang (CR22) 1994; 91 Omay, Vogelbaum (CR3) 2009; 46 Li, Schmitz, Jeffrey, Wiltzius, Kussie, Ferguson (CR10) 2005; 7 Lammering, Hewit, Valerie, Contessa, Amorino, Dent, Schmidt-Ullrich (CR29) 2003; 22 Stupp, Mason, van den Bent, Weller, Fisher, Taphoorn, Belanger, Brandes, Marosi, Bogdahn, Curschmann, Janzer, Ludwin, Gorlia, Allgeier, Lacombe, Cairncross, Eisenhauer, Mirimanoff (CR2) 2005; 352 Diaz Miqueli, Rolff, Lemm, Fichtner, Perez, Montero (CR36) 2009; 100 Maier-Hauff, Ulrich, Nestler, Niehoff, Wust, Thiesen, Orawa, Budach, Jordan (CR16) 2011; 103 Zimmer, Weissleder, Poss, Bogdanova, Wright, Enochs (CR39) 1995; 197 Villanueva, Canete, Roca, Calero, Veintemillas-Verdaguer, Serna, Morales Mdel, Miranda (CR42) 2009; 20 Jordan, Scholz, Maier-Hauff, van Landeghem, Waldoefner, Teichgraeber, Pinkernelle, Bruhn, Neumann, Thiesen, von Deimling, Felix (CR18) 2006; 78 Moore, Marecos, Bogdanov, Weissleder (CR40) 2000; 214 Ahamed, Alhadlaq, Khan, Akhtar (CR26) 2013; 15 Jackson, Bartek (CR23) 2009; 461 Nagane, Coufal, Lin, Bogler, Cavenee, Huang (CR21) 1996; 56 Yamamori, Yasui, Yamazumi, Wada, Nakamura, Nakamura, Inanami (CR25) 2012; 53 Hadjipanayis, Bonder, Balakrishnan, Wang, Mao, Hadjipanayis (CR17) 2008; 4 Reddy, Bhojani, McConville, Moody, Moffat, Hall, Kim, Koo, Woolliscroft, Sugai, Johnson, Philbert, Kopelman, Rehemtulla, Ross (CR35) 2006; 12 Li, Yuan, Kim, Chang, Bernhard, Shu (CR28) 2004; 23 Braun, Oppermann, Mueller, Renner, Hovhannisyan, Baran-Schmidt, Gebhardt, Hipkiss, Thiery, Meixensberger, Gaunitz (CR1) 2012; 13 20647323 - Cancer Res. 2010 Aug 1;70(15):6303-12 18765536 - Clin Cancer Res. 2008 Sep 1;14(17):5447-58 18752211 - Small. 2008 Nov;4(11):1925-9 19346642 - Indian J Cancer. 2009 Apr-Jun;46(2):88-95 19435898 - Cancer Res. 2009 May 15;69(10):4252-9 23576486 - Oncologist. 2013;18(4):460-6 19242401 - Clin Pharmacol Ther. 2009 May;85(5):531-4 22580337 - Free Radic Biol Med. 2012 Jul 15;53(2):260-70 15617598 - Neurosurgery. 2005;56(1):155-62; discussion 162 25871395 - Oncotarget. 2015 Apr 20;6(11):8788-806 15450724 - Radiother Oncol. 2004 Sep;72(3):267-73 12947383 - Oncogene. 2003 Sep 1;22(37):5734-54 21419873 - Nanomedicine. 2011 Dec;7(6):744-52 18772396 - Science. 2008 Sep 26;321(5897):1807-12 18403491 - Neuro Oncol. 2008 Jun;10(3):320-9 19324552 - J Clin Neurosci. 2009 Jun;16(6):748-54 19617446 - AJNR Am J Neuroradiol. 2009 Aug;30(7):1293-301 7480707 - Radiology. 1995 Nov;197(2):533-8 20845061 - J Neurooncol. 2011 Jun;103(2):317-24 22406999 - Cancer Biol Ther. 2012 May;13(7):487-95 22216932 - Chem Rev. 2012 Apr 11;112(4):2323-38 19847258 - Nature. 2009 Oct 22;461(7267):1071-8 8134351 - Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2076-80 18610740 - In Vivo. 2008 May-Jun;22(3):305-9 19293809 - Br J Cancer. 2009 Mar 24;100(6):950-8 19420433 - Nanotechnology. 2009 Mar 18;20(11):115103 15837620 - Cancer Cell. 2005 Apr;7(4):301-11 10671613 - Radiology. 2000 Feb;214(2):568-74 22960522 - Clin Neurosurg. 2012;59:107-13 18728637 - Mol Ther. 2008 Nov;16(11):1783-8 15758009 - N Engl J Med. 2005 Mar 10;352(10):987-96 8895767 - Cancer Res. 1996 Nov 1;56(21):5079-86 22842461 - Biochem Biophys Res Commun. 2012 Aug 24;425(2):393-7 12235219 - J Clin Oncol. 2002 Sep 15;20(18 Suppl):1S-13S 24135280 - Cancer Cell. 2013 Oct 14;24(4):438-49 17121886 - Clin Cancer Res. 2006 Nov 15;12(22):6677-86 18232053 - Small. 2008 Mar;4(3):372-9 12234411 - Neurosurgery. 2002 Oct;51(4):1005-13; discussion 1013-4 15077177 - Oncogene. 2004 Jun 3;23(26):4594-602 8052651 - Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7727-31 16929166 - Cancer Biol Ther. 2006 Aug;5(8):912-4 16314937 - J Neurooncol. 2006 May;78(1):7-14 12944901 - Oncogene. 2003 Aug 28;22(36):5545-53 21557708 - Expert Opin Biol Ther. 2011 Jul;11(7):937-49 RH Bobo (1807_CR45) 1994; 91 CG Hadjipanayis (1807_CR17) 2008; 4 DA Orringer (1807_CR31) 2009; 85 JL Eller (1807_CR13) 2002; 51 A Diaz Miqueli (1807_CR36) 2009; 100 M Mahmoudi (1807_CR19) 2012; 112 RB Mikkelsen (1807_CR38) 2003; 22 G Lammering (1807_CR29) 2003; 22 A Villanueva (1807_CR42) 2009; 20 CR Garrett (1807_CR8) 2011; 11 G Lammering (1807_CR27) 2004; 72 S Platt (1807_CR15) 2012; 59 GR Reddy (1807_CR35) 2006; 12 LJ Kuo (1807_CR24) 2008; 22 QW Fan (1807_CR30) 2013; 24 JM Provenzale (1807_CR32) 2009; 30 JL Eller (1807_CR37) 2005; 56 A Moore (1807_CR40) 2000; 214 R Stupp (1807_CR2) 2005; 352 DW Parsons (1807_CR4) 2008; 321 R Nishikawa (1807_CR22) 1994; 91 MH Cohen (1807_CR9) 2013; 18 C Belda-Iniesta (1807_CR12) 2006; 5 M Ahamed (1807_CR26) 2013; 15 T Martens (1807_CR11) 2008; 14 B Mukherjee (1807_CR6) 2009; 69 A Jordan (1807_CR18) 2006; 78 CG Hadjipanayis (1807_CR43) 2008; 16 SB Omay (1807_CR3) 2009; 46 J Mendelsohn (1807_CR7) 2002; 20 C Sun (1807_CR34) 2008; 4 JH Sampson (1807_CR44) 2008; 10 S Braun (1807_CR1) 2012; 13 K Maier-Hauff (1807_CR16) 2011; 103 C Zimmer (1807_CR39) 1995; 197 SP Jackson (1807_CR23) 2009; 461 T Yamamori (1807_CR25) 2012; 53 G Caruso (1807_CR33) 2011; 7 CG Hadjipanayis (1807_CR20) 2010; 70 1807_CR14 M Nagane (1807_CR21) 1996; 56 B Li (1807_CR28) 2004; 23 HK Gan (1807_CR5) 2009; 16 S Li (1807_CR10) 2005; 7 S Klein (1807_CR41) 2012; 425 |
References_xml | – volume: 78 start-page: 7 issue: 1 year: 2006 end-page: 14 ident: CR18 article-title: The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma publication-title: J Neurooncol doi: 10.1007/s11060-005-9059-z contributor: fullname: Felix – volume: 59 start-page: 107 year: 2012 end-page: 113 ident: CR15 article-title: Canine model of convection-enhanced delivery of cetuximab-conjugated iron-oxide nanoparticles monitored with magnetic resonance imaging publication-title: Clin Neurosurg doi: 10.1227/NEU.0b013e31826989ef contributor: fullname: Hadjipanayis – volume: 91 start-page: 2076 issue: 6 year: 1994 end-page: 2080 ident: CR45 article-title: Convection-enhanced delivery of macromolecules in the brain publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.91.6.2076 contributor: fullname: Oldfield – volume: 72 start-page: 267 issue: 3 year: 2004 end-page: 273 ident: CR27 article-title: Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance publication-title: Radiother Oncol doi: 10.1016/j.radonc.2004.07.004 contributor: fullname: Schmidt-Ullrich – volume: 53 start-page: 260 issue: 2 year: 2012 end-page: 270 ident: CR25 article-title: Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2012.04.033 contributor: fullname: Inanami – ident: CR14 – volume: 16 start-page: 748 issue: 6 year: 2009 end-page: 754 ident: CR5 article-title: The EGFRvIII variant in glioblastoma multiforme publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2008.12.005 contributor: fullname: Luwor – volume: 24 start-page: 438 issue: 4 year: 2013 end-page: 449 ident: CR30 article-title: EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.09.004 contributor: fullname: Weiss – volume: 22 start-page: 305 issue: 3 year: 2008 end-page: 309 ident: CR24 article-title: Gamma-H2AX—a novel biomarker for DNA double-strand breaks publication-title: In Vivo contributor: fullname: Yang – volume: 15 start-page: 1225 issue: 1 year: 2013 ident: CR26 article-title: Selective killing of cancer cells by iron oxide nanoparticles mediated through reactive oxygen species via p53 pathway publication-title: J Nanopart Res doi: 10.1007/s11051-012-1225-6 contributor: fullname: Akhtar – volume: 91 start-page: 7727 issue: 16 year: 1994 end-page: 7731 ident: CR22 article-title: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.91.16.7727 contributor: fullname: Huang – volume: 56 start-page: 155 issue: 1 year: 2005 ident: CR37 article-title: Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo publication-title: Neurosurgery contributor: fullname: Canute – volume: 10 start-page: 320 issue: 3 year: 2008 end-page: 329 ident: CR44 article-title: Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors publication-title: Neuro Oncol doi: 10.1215/15228517-2008-012 contributor: fullname: Bigner – volume: 20 start-page: 115103 issue: 11 year: 2009 ident: CR42 article-title: The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells publication-title: Nanotechnology doi: 10.1088/0957-4484/20/11/115103 contributor: fullname: Miranda – volume: 461 start-page: 1071 issue: 7267 year: 2009 end-page: 1078 ident: CR23 article-title: The DNA-damage response in human biology and disease publication-title: Nature doi: 10.1038/nature08467 contributor: fullname: Bartek – volume: 18 start-page: 460 issue: 4 year: 2013 end-page: 466 ident: CR9 article-title: Approval summary: cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer publication-title: Oncologist doi: 10.1634/theoncologist.2012-0458 contributor: fullname: Pazdur – volume: 4 start-page: 1925 issue: 11 year: 2008 end-page: 1929 ident: CR17 article-title: Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia publication-title: Small doi: 10.1002/smll.200800261 contributor: fullname: Hadjipanayis – volume: 23 start-page: 4594 issue: 26 year: 2004 end-page: 4602 ident: CR28 article-title: Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin publication-title: Oncogene doi: 10.1038/sj.onc.1207602 contributor: fullname: Shu – volume: 22 start-page: 5545 issue: 36 year: 2003 end-page: 5553 ident: CR29 article-title: EGFRvIII-mediated radioresistance through a strong cytoprotective response publication-title: Oncogene doi: 10.1038/sj.onc.1206788 contributor: fullname: Schmidt-Ullrich – volume: 13 start-page: 487 issue: 7 year: 2012 end-page: 495 ident: CR1 article-title: Hedgehog signaling in glioblastoma multiforme publication-title: Cancer Biol Ther doi: 10.4161/cbt.19591 contributor: fullname: Gaunitz – volume: 22 start-page: 5734 issue: 37 year: 2003 end-page: 5754 ident: CR38 article-title: Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms publication-title: Oncogene doi: 10.1038/sj.onc.1206663 contributor: fullname: Wardman – volume: 46 start-page: 88 issue: 2 year: 2009 end-page: 95 ident: CR3 article-title: Current concepts and newer developments in the treatment of malignant gliomas publication-title: Indian J Cancer doi: 10.4103/0019-509X.49146 contributor: fullname: Vogelbaum – volume: 51 start-page: 1005 issue: 4 year: 2002 ident: CR13 article-title: Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme publication-title: Neurosurgery contributor: fullname: Canute – volume: 425 start-page: 393 issue: 2 year: 2012 end-page: 397 ident: CR41 article-title: Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2012.07.108 contributor: fullname: Kryschi – volume: 11 start-page: 937 issue: 7 year: 2011 end-page: 949 ident: CR8 article-title: Cetuximab in the treatment of patients with colorectal cancer publication-title: Expert Opin Biol Ther doi: 10.1517/14712598.2011.582464 contributor: fullname: Eng – volume: 103 start-page: 317 issue: 2 year: 2011 end-page: 324 ident: CR16 article-title: Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme publication-title: J Neurooncol doi: 10.1007/s11060-010-0389-0 contributor: fullname: Jordan – volume: 321 start-page: 1807 issue: 5897 year: 2008 end-page: 1812 ident: CR4 article-title: An integrated genomic analysis of human glioblastoma multiforme publication-title: Science doi: 10.1126/science.1164382 contributor: fullname: Kinzler – volume: 30 start-page: 1293 issue: 7 year: 2009 end-page: 1301 ident: CR32 article-title: Uses of nanoparticles for central nervous system imaging and therapy publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A1590 contributor: fullname: Silva – volume: 7 start-page: 301 issue: 4 year: 2005 end-page: 311 ident: CR10 article-title: Structural basis for inhibition of the epidermal growth factor receptor by cetuximab publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.03.003 contributor: fullname: Ferguson – volume: 14 start-page: 5447 issue: 17 year: 2008 end-page: 5458 ident: CR11 article-title: Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-0147 contributor: fullname: Lamszus – volume: 56 start-page: 5079 issue: 21 year: 1996 end-page: 5086 ident: CR21 article-title: A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis publication-title: Cancer Res contributor: fullname: Huang – volume: 4 start-page: 372 issue: 3 year: 2008 end-page: 379 ident: CR34 article-title: In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes publication-title: Small doi: 10.1002/smll.200700784 contributor: fullname: Zhang – volume: 197 start-page: 533 issue: 2 year: 1995 end-page: 538 ident: CR39 article-title: MR imaging of phagocytosis in experimental gliomas publication-title: Radiology doi: 10.1148/radiology.197.2.7480707 contributor: fullname: Enochs – volume: 7 start-page: 744 issue: 6 year: 2011 end-page: 752 ident: CR33 article-title: Could nanoparticle systems have a role in the treatment of cerebral gliomas? publication-title: Nanomedicine doi: 10.1016/j.nano.2011.02.008 contributor: fullname: Tomasello – volume: 12 start-page: 6677 issue: 22 year: 2006 end-page: 6686 ident: CR35 article-title: Vascular targeted nanoparticles for imaging and treatment of brain tumors publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-0946 contributor: fullname: Ross – volume: 5 start-page: 912 issue: 8 year: 2006 end-page: 914 ident: CR12 article-title: Long term responses with cetuximab therapy in glioblastoma multiforme publication-title: Cancer Biol Ther doi: 10.4161/cbt.5.8.3118 contributor: fullname: Baron – volume: 352 start-page: 987 issue: 10 year: 2005 end-page: 996 ident: CR2 article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma publication-title: N Engl J Med doi: 10.1056/NEJMoa043330 contributor: fullname: Mirimanoff – volume: 16 start-page: 1783 issue: 11 year: 2008 end-page: 1788 ident: CR43 article-title: Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery publication-title: Mol Ther doi: 10.1038/mt.2008.185 contributor: fullname: Deluca – volume: 20 start-page: 1s issue: 18 Suppl year: 2002 end-page: 13s ident: CR7 article-title: Targeting the epidermal growth factor receptor for cancer therapy publication-title: J Clin Oncol contributor: fullname: Mendelsohn – volume: 70 start-page: 6303 issue: 15 year: 2010 end-page: 6312 ident: CR20 article-title: EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-1022 contributor: fullname: Mao – volume: 112 start-page: 2323 issue: 4 year: 2012 end-page: 2338 ident: CR19 article-title: Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles publication-title: Chem Rev doi: 10.1021/cr2002596 contributor: fullname: Petri-Fink – volume: 214 start-page: 568 issue: 2 year: 2000 end-page: 574 ident: CR40 article-title: Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model publication-title: Radiology doi: 10.1148/radiology.214.2.r00fe19568 contributor: fullname: Weissleder – volume: 85 start-page: 531 issue: 5 year: 2009 end-page: 534 ident: CR31 article-title: Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2008.296 contributor: fullname: Philbert – volume: 100 start-page: 950 issue: 6 year: 2009 end-page: 958 ident: CR36 article-title: Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604943 contributor: fullname: Montero – volume: 69 start-page: 4252 issue: 10 year: 2009 end-page: 4259 ident: CR6 article-title: EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-4853 contributor: fullname: Burma – volume: 22 start-page: 5545 issue: 36 year: 2003 ident: 1807_CR29 publication-title: Oncogene doi: 10.1038/sj.onc.1206788 contributor: fullname: G Lammering – volume: 15 start-page: 1225 issue: 1 year: 2013 ident: 1807_CR26 publication-title: J Nanopart Res doi: 10.1007/s11051-012-1225-6 contributor: fullname: M Ahamed – volume: 23 start-page: 4594 issue: 26 year: 2004 ident: 1807_CR28 publication-title: Oncogene doi: 10.1038/sj.onc.1207602 contributor: fullname: B Li – volume: 56 start-page: 155 issue: 1 year: 2005 ident: 1807_CR37 publication-title: Neurosurgery doi: 10.1227/01.NEU.0000145865.25689.55 contributor: fullname: JL Eller – ident: 1807_CR14 doi: 10.18632/oncotarget.3554 – volume: 13 start-page: 487 issue: 7 year: 2012 ident: 1807_CR1 publication-title: Cancer Biol Ther doi: 10.4161/cbt.19591 contributor: fullname: S Braun – volume: 112 start-page: 2323 issue: 4 year: 2012 ident: 1807_CR19 publication-title: Chem Rev doi: 10.1021/cr2002596 contributor: fullname: M Mahmoudi – volume: 4 start-page: 372 issue: 3 year: 2008 ident: 1807_CR34 publication-title: Small doi: 10.1002/smll.200700784 contributor: fullname: C Sun – volume: 214 start-page: 568 issue: 2 year: 2000 ident: 1807_CR40 publication-title: Radiology doi: 10.1148/radiology.214.2.r00fe19568 contributor: fullname: A Moore – volume: 69 start-page: 4252 issue: 10 year: 2009 ident: 1807_CR6 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-4853 contributor: fullname: B Mukherjee – volume: 11 start-page: 937 issue: 7 year: 2011 ident: 1807_CR8 publication-title: Expert Opin Biol Ther doi: 10.1517/14712598.2011.582464 contributor: fullname: CR Garrett – volume: 24 start-page: 438 issue: 4 year: 2013 ident: 1807_CR30 publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.09.004 contributor: fullname: QW Fan – volume: 12 start-page: 6677 issue: 22 year: 2006 ident: 1807_CR35 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-0946 contributor: fullname: GR Reddy – volume: 53 start-page: 260 issue: 2 year: 2012 ident: 1807_CR25 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2012.04.033 contributor: fullname: T Yamamori – volume: 72 start-page: 267 issue: 3 year: 2004 ident: 1807_CR27 publication-title: Radiother Oncol doi: 10.1016/j.radonc.2004.07.004 contributor: fullname: G Lammering – volume: 22 start-page: 305 issue: 3 year: 2008 ident: 1807_CR24 publication-title: In Vivo contributor: fullname: LJ Kuo – volume: 91 start-page: 2076 issue: 6 year: 1994 ident: 1807_CR45 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.91.6.2076 contributor: fullname: RH Bobo – volume: 14 start-page: 5447 issue: 17 year: 2008 ident: 1807_CR11 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-0147 contributor: fullname: T Martens – volume: 10 start-page: 320 issue: 3 year: 2008 ident: 1807_CR44 publication-title: Neuro Oncol doi: 10.1215/15228517-2008-012 contributor: fullname: JH Sampson – volume: 5 start-page: 912 issue: 8 year: 2006 ident: 1807_CR12 publication-title: Cancer Biol Ther doi: 10.4161/cbt.5.8.3118 contributor: fullname: C Belda-Iniesta – volume: 20 start-page: 115103 issue: 11 year: 2009 ident: 1807_CR42 publication-title: Nanotechnology doi: 10.1088/0957-4484/20/11/115103 contributor: fullname: A Villanueva – volume: 51 start-page: 1005 issue: 4 year: 2002 ident: 1807_CR13 publication-title: Neurosurgery contributor: fullname: JL Eller – volume: 425 start-page: 393 issue: 2 year: 2012 ident: 1807_CR41 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2012.07.108 contributor: fullname: S Klein – volume: 56 start-page: 5079 issue: 21 year: 1996 ident: 1807_CR21 publication-title: Cancer Res contributor: fullname: M Nagane – volume: 30 start-page: 1293 issue: 7 year: 2009 ident: 1807_CR32 publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A1590 contributor: fullname: JM Provenzale – volume: 7 start-page: 744 issue: 6 year: 2011 ident: 1807_CR33 publication-title: Nanomedicine doi: 10.1016/j.nano.2011.02.008 contributor: fullname: G Caruso – volume: 85 start-page: 531 issue: 5 year: 2009 ident: 1807_CR31 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2008.296 contributor: fullname: DA Orringer – volume: 100 start-page: 950 issue: 6 year: 2009 ident: 1807_CR36 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604943 contributor: fullname: A Diaz Miqueli – volume: 352 start-page: 987 issue: 10 year: 2005 ident: 1807_CR2 publication-title: N Engl J Med doi: 10.1056/NEJMoa043330 contributor: fullname: R Stupp – volume: 197 start-page: 533 issue: 2 year: 1995 ident: 1807_CR39 publication-title: Radiology doi: 10.1148/radiology.197.2.7480707 contributor: fullname: C Zimmer – volume: 70 start-page: 6303 issue: 15 year: 2010 ident: 1807_CR20 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-1022 contributor: fullname: CG Hadjipanayis – volume: 461 start-page: 1071 issue: 7267 year: 2009 ident: 1807_CR23 publication-title: Nature doi: 10.1038/nature08467 contributor: fullname: SP Jackson – volume: 16 start-page: 1783 issue: 11 year: 2008 ident: 1807_CR43 publication-title: Mol Ther doi: 10.1038/mt.2008.185 contributor: fullname: CG Hadjipanayis – volume: 20 start-page: 1s issue: 18 Suppl year: 2002 ident: 1807_CR7 publication-title: J Clin Oncol contributor: fullname: J Mendelsohn – volume: 4 start-page: 1925 issue: 11 year: 2008 ident: 1807_CR17 publication-title: Small doi: 10.1002/smll.200800261 contributor: fullname: CG Hadjipanayis – volume: 321 start-page: 1807 issue: 5897 year: 2008 ident: 1807_CR4 publication-title: Science doi: 10.1126/science.1164382 contributor: fullname: DW Parsons – volume: 78 start-page: 7 issue: 1 year: 2006 ident: 1807_CR18 publication-title: J Neurooncol doi: 10.1007/s11060-005-9059-z contributor: fullname: A Jordan – volume: 46 start-page: 88 issue: 2 year: 2009 ident: 1807_CR3 publication-title: Indian J Cancer doi: 10.4103/0019-509X.49146 contributor: fullname: SB Omay – volume: 16 start-page: 748 issue: 6 year: 2009 ident: 1807_CR5 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2008.12.005 contributor: fullname: HK Gan – volume: 59 start-page: 107 year: 2012 ident: 1807_CR15 publication-title: Clin Neurosurg doi: 10.1227/NEU.0b013e31826989ef contributor: fullname: S Platt – volume: 103 start-page: 317 issue: 2 year: 2011 ident: 1807_CR16 publication-title: J Neurooncol doi: 10.1007/s11060-010-0389-0 contributor: fullname: K Maier-Hauff – volume: 91 start-page: 7727 issue: 16 year: 1994 ident: 1807_CR22 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.91.16.7727 contributor: fullname: R Nishikawa – volume: 18 start-page: 460 issue: 4 year: 2013 ident: 1807_CR9 publication-title: Oncologist doi: 10.1634/theoncologist.2012-0458 contributor: fullname: MH Cohen – volume: 7 start-page: 301 issue: 4 year: 2005 ident: 1807_CR10 publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.03.003 contributor: fullname: S Li – volume: 22 start-page: 5734 issue: 37 year: 2003 ident: 1807_CR38 publication-title: Oncogene doi: 10.1038/sj.onc.1206663 contributor: fullname: RB Mikkelsen |
SSID | ssj0004731 |
Score | 2.44308 |
Snippet | The epidermal growth factor receptor deletion variant EGFRvIII is known to be expressed in a subset of patients with glioblastoma (GBM) tumors that enhances... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 13 |
SubjectTerms | Animals Antineoplastic Agents - administration & dosage Apoptosis - drug effects Brain Neoplasms - drug therapy Brain Neoplasms - pathology Brain Neoplasms - radiotherapy Cell Line, Tumor Cetuximab - administration & dosage DNA Damage - drug effects Drug Delivery Systems Ferric Compounds - chemistry Glioblastoma - drug therapy Glioblastoma - pathology Glioblastoma - radiotherapy Humans Laboratory Investigation Magnetite Nanoparticles - chemistry Medicine Medicine & Public Health Mice Neurology Oncology Radiation Tolerance Reactive Oxygen Species Receptor, Epidermal Growth Factor - administration & dosage Receptor, Epidermal Growth Factor - immunology |
SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3ZbtNAcFRSCfFCuTG0aJF4Am3ka732Y4V6CFQeEJXCk7WXm7RlXTWOBHxDP5oZHwkhgNQ32ztr7TE7O_cAvFEKyWIRVTyykeGp1AlXpsi5yV2SWMp5VpFq4ORTdnyafpiIyRbES9WFvxgPFsmWUK9i3VB4IR8qwaOc1Gt3YFtQvq8RbO8fff14sIqGlH0VQiQBokgngy3zbz9Zv402WMxNT8k_zKXtLXS400UGztvkheR8cjFeNHpsfm6mdrzFBB_A_Z4pZfsdFj2ELecfwd2T3uz-GG4-Kzur5-Tr3hWbYM5PCV1Itcjqil1TOwruxIzil7PLWa2RLW_qb4pphKYytHgDXLIzlPqbKeuq_DCktu6KHrDTTNf2B0fp_HxBmj3LKP6O19-xJ_PKo2zfu_A9gdPDgy_vj3lfxoGbLIwbHmnccGdINMoTLeMkTeNIFdKqSuQm1pnN8VLMCmUSG4Va4Kt2Lq1EIl0WIso8hZGvvXsOzGlbUHUUISNNnIdWiFxIQZSOrU6lCeDtsJ3lVZeto1zlZab1LXF9S1rfMgxgd9jwsj-48zLKCqp4I2QcwOtlMx45sqMo7-pFByNRThPhf2AkMmJUTD4P4FmHQ8sRocRJEfZJAHINu5YAlPJ7vcXPpm3q7zQtciSZAbwbcOi3of9roi9uBf0S7sWEhK2T4y6MmuuF20PGq9Gv-pP2C1qKKOQ priority: 102 providerName: Springer Nature |
Title | Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles |
URI | https://link.springer.com/article/10.1007/s11060-015-1807-0 https://www.ncbi.nlm.nih.gov/pubmed/25981803 https://www.proquest.com/docview/1695133572 https://search.proquest.com/docview/1695757650 https://search.proquest.com/docview/1709182368 https://pubmed.ncbi.nlm.nih.gov/PMC4498963 |
Volume | 124 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD5iq4R4QdyXMSoj8QSyqBMnTp5QO7VMoFVoolJ5iuzYWYtGUtZUGv-BH805ubSUib30ZkdK-h0fn5vPB_BGa1SLici5sCLjUpmA6yyJeRa7ILDU8yyn0MD5NDqbyU_zcN4G3NZtWWWnE2tFbcuMYuTvRZQQFUmo_A-rn5xYoyi72lJoHEDPF5LStL3RePrlYncyUrWMhKgOwkTOu7xmfXgOvSEqygq5iClet78z3TI3b1dN_pM6rXekySN42JqSbNhg_xjuueIJ3D9vk-VP4feFtstyTRXqDUUEc8WCQKaAICtzdk3j6G6TCYm_XF4tS4PGdFX-0MzgbCKPRb19xS7RV68WrOHmYagj3Yo-4EVLU9pfHH3q7xuKx1lGp-Z4eYNXskIX6JG3hXfPYDYZfz094y35As-igV9xYRAml5FDEwdG-YGUvtCJsjoP48w3kY1xK4sSnQVWDEyIX41zMg8D5aIBAv0cDouycEfAnLEJcZqEShiyF4xGkcB1r41vjVSZB2-7Pz5dNT020l03ZUIpRZRSQikdeHDSQZO2y22d7oTDg9fbYVwolP3QhSs3zRyF3lU4uGOOQvOJKOBjD140aG_vCP1EOhcfeKD25GA7gRp1748Uy0XdsFvKJEZF58G7TmL-uvX_Pejx3Q_6Eh74JLt1LeIJHFbXG_cK7aPK9OFAzRW-xqeiD73hZDSa0vvHb5_H_XaB4OjMH_4B6c0XuA |
link.rule.ids | 230,315,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,41114,41556,42183,42625,43343,43612,43838,52144,52267,74100,74369,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwEB7BIgEXxJvAAkbiBLLIw46TE0IrVgW2e0C7Um-RHTvboiUu21SC_8CPZiZxWsqKvaWxIyX9xuN5eT6A11qjWiyThic2qblQJuO6LgteFy7LLPU8ayg0MD3OJ6fi80zOQsBtFcoqR53YK2rra4qRv0vykqhIpErfL39wYo2i7Gqg0LgON0SGezWdFD_YlngIFfgIURnIUszGrGZ_dA59ISrJkjwpKFq3uy9dMjYv10z-kzjt96PDu3AnGJLsw4D8Pbjm2vtwcxpS5Q_g91dtF35F9ekDQQRz7ZwgpnAg8w27oHF0tsmAxDtn5wtv0JTu_HfNDM4m6ljU2ufsDD31bs4GZh6GGtIt6QIfWhhvf3H0qL-tKRpnGZ2Z4_4nPsla3aI_HsruHsLp4ceTgwkP1Au8zuO044lBkFxN7kyRGZVmQqSJLpXVjSzq1OS2wI0sL3Wd2SQ2En8a50QjM-XyGGF-BHutb90TYM7YkhhNpEoMWQtGo0DgqtcmtUaoOoI34x9fLYcOG9W2lzKhVCFKFaFUxRHsj9BUYbGtqq1oRPBqM4zLhHIfunV-PcxR6FvJ-Io5Co0nIoAvIng8oL15I_QS6VR8FoHakYPNBGrTvTvSLuZ9u24hygLVXARvR4n569X_96FPr_7Ql3BrcjI9qo4-HX95BrdTkuO-KnEf9rqLtXuOllJnXvTL4Q9G0xNd |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwEB5BkSpeEHcDBYzEE8hqDjtOnhAqrMrRCiEq7VvkK91FJVm6WQn-Az-amcTZZanoWzZ2pGRnPJ7j83wAL7RGs1gmNU9cYrlQJuPalgW3hc8yRz3PakoNHJ_kR6fiw1ROA_5pGWCVo03sDbVrLeXID5K8JCoSqdKDOsAiPr-dvF784MQgRZXWQKdxHW7grpiThheHG7iHUIGbEA2DLMV0rHD2x-gwLiJ4luRJQZm77T3qkuN5GT_5TxG135smt-FWcCrZm0EL7sA139yF3eNQNr8Hv79oN2-XhFUfyCKYb2YkbkoNsrZmFzSOgTc5k3jn7HzeGnSru_a7ZgZnE40sWvBzdoZRezdjA0sPQ2vpF3SBD81N635xjK6_rSgz5xidn-PtT3ySNbrB2DxA8O7D6eTd18MjHmgYuM3jtOOJQYF5S6FNkRmVZkKkiS6V07UsbGpyV-CmlpfaZi6JjcSfxntRy0z5PEaRP4Cdpm38HjBvXEnsJlIlhjwHo1E50AJokzojlI3g5fjHV4uh20a16atMUqpQShVJqYoj2B9FU4WFt6w2ahLB8_UwLhmqg-jGt6thjsI4S8ZXzFHoSBEZfBHBw0Ha6zfCiJFOyGcRqC09WE-glt3bI8181rfuFqIs0ORF8GrUmL9e_X8f-ujqD30Gu7gSqk_vTz4-hpspqXEPUNyHne5i5Z-g09SZp_1q-AM8Zheb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Radiosensitivity+enhancement+of+radioresistant+glioblastoma+by+epidermal+growth+factor+receptor+antibody-conjugated+iron-oxide+nanoparticles&rft.jtitle=Journal+of+neuro-oncology&rft.au=Bouras%2C+Alexandros&rft.au=Kaluzova%2C+Milota&rft.au=Hadjipanayis%2C+Costas+G&rft.date=2015-08-01&rft.pub=Springer+Nature+B.V&rft.issn=0167-594X&rft.eissn=1573-7373&rft.volume=124&rft.issue=1&rft.spage=13&rft_id=info:doi/10.1007%2Fs11060-015-1807-0&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3739184121 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-594X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-594X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-594X&client=summon |